Table 1:
Subjects | Entire Cohort (n=27) | Neonates (n=17) | Older Children (n=10) | P-value |
---|---|---|---|---|
Age at repair [yr] | 0.70 (0.01, 11.06) | 0.05 (0.01, 2.34) | 5.46 (2.54, 11.06) | < .0001 |
Weight at repair [kg] | 5.90 (3.10, 81.8) | 3.82 (3.10, 13.10) | 20.55 (12.4, 81.8) | <.0001 |
Male Gender [n] | 20 (74%) | 12 (71%) | 8 (80%) | 0.6784 |
Cardio-Pulmonary Bypass [n] | 5 (18.5%) | 5 (29.4%) | 0 (0%) | 0.1240 |
Time to follow up [d] | 260 (108, 544) | 271 (108, 431) | 252 (191, 544) | 0.7756 |
Anti-hypertensive therapy pre-op [n] | 5 (15.5%) | 1 (5.9%) | 4 (40.0%) | 0.0473 |
Anti-hypertensive therapy at discharge [n] | 19 (70.4%) | 9 (52.9%) | 10 (100%) | 0.0119 |
Anti-hypertensive therapy at follow-up [n] | 8 (33.3%) | 4 (25.0%) | 4 (50.0%) | 0.3625 |
Residual outflow obstruction [n] | 5 (21.7%) | 4(26.7%) | 1 (12.5%) | 0.6214 |
Data presented as n (%) or median (range). P-values refer to comparison between neonatal and older children groups.